Tempest Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Ratings actions from Benzinga: GMT) Tempest Therapeutics Price Target Cut to $7.00/Share From $11.00 by HC Wainwright & Co.Ratings actions from Benzinga
Related stories
South Korea’s Finance Ministry To Extend Temporary Fuel Tax Cuts By Two Months Through End-January
L impact | NEWS | Nov 11, 2026, 12:46 AM UTC
Australia Home Loans Value (Q/Q) Q3: -15.5% (est -8.0%; prev -5.2%)
Owner-Occupier Loan Value (Q/Q): -5.3% (prev -1.9%) - Investor Loan Value (Q/Q): -32.3% (prev -10.2%)
L impact | NEWS | Nov 11, 2026, 12:41 AM UTC
Japan Yield On 40-Year JGB Falls 0.5bps To 4.055%
L impact | NEWS | Nov 11, 2026, 12:23 AM UTC
South Korea finance minister: will unveil fuel price cap policy on Nov. 13
L impact | NEWS | Nov 11, 2026, 12:18 AM UTC
South Korea fin min: to prolong temporary fuel tax reductions by 2 months through end-Jan
L impact | NEWS | Nov 11, 2026, 12:17 AM UTC
Japan Yield On 10-Year JGB Rises 5.5bps To 2.745%
L impact | NEWS | Nov 11, 2026, 12:15 AM UTC